TheraCryf narrows loss, advances drug programmes after acquisition
28th Nov 2024 14:25
(Alliance News) - TheraCryf PLC said on Thusday its half-year pretax loss narrowed as it advanced drug development programmes in oncology and neuropsychiatry while integrating assets from a recent acquisition. Read More